THE Federal Government is investing $10 million to fund six new rare cancer and rare disease clinical trials focused on improving survival rates with new treatments.
The six new clinical trials will target pancreatic cancer, traumatic brain injury, rare skin tumours, myeloma, myelofibrosis and a pioneering treatment for high mortality cancers, such as glioblastoma, with some having a five year survival rate as low as 8%.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Sep 18
